CE Exam Based Reference Study Guide
Last Updated: 04/16/2026
Table of Contents
Cardiovascular
| Wolk MJ, Bailey SR, Doherty JU, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;63(4):380-406. doi:10.1016/j.jacc.2013.11.009 https://pubmed.ncbi.nlm.nih.gov/24355759/ |
| Schwaiger M, Brunken RC, Krivokapich J, Child JS, Tillisch JH, Phelps ME, Schelbert HR. Beneficial effect of residual anterograde flow on tissue viability as assessed by positron emission tomography in patients with myocardial infarction. Eur Heart J. 1987 Sep;8(9):981-8. doi: 10.1093/oxfordjournals.eurheartj.a062375. PMID: 3499320. |
| Botvinick EH. Current methods of pharmacologic stress testing and the potential advantages of new agents. J Nucl Med Technol. 2009;37(1):14-25. doi:10.2967/jnmt.108.057802 https://pubmed.ncbi.nlm.nih.gov/19258260/ |
| Yetman TJ, Dudzinski MR. Effects of massive ascites on measurement of cardiac ejection fraction via multi-gated acquisition (MUGA) scanning. Gynecol Oncol. 1989;34(1):116-118. doi:10.1016/0090-8258(89)90120-0 https://pubmed.ncbi.nlm.nih.gov/2737517/ |
| Slart RHJA; Writing group; Reviewer group; FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45(7):1250-1269. doi:10.1007/s00259-018-3973-8 |
| Ohira H, Tsujino I, Yoshinaga K. ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2011;38(9):1773-1783. doi:10.1007/s00259-011-1832-y https://pubmed.ncbi.nlm.nih.gov/21559980/ |
| Selvaraj S, Bravo PE. How to prepare a patient for 18F-fluorodeoxyglucose positron emission tomography imaging to assess myocardial inflammation. J Nucl Cardiol. 2024;38:101888. doi:10.1016/j.nuclcard.2024.101888 |
| Fallavollita JA, Luisi AJ Jr, Yun E, deKemp RA, Canty JM Jr. An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy. J Nucl Cardiol. 2010;17(4):637-645. doi:10.1007/s12350-010-9228-0 https://pubmed.ncbi.nlm.nih.gov/20387134/ Vitale GD, deKemp RA, Ruddy TD, Williams K, Beanlands RS. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. J Nucl Med. 2001;42(12):1730-1736. https://pubmed.ncbi.nlm.nih.gov/11752067/ |
| Cerci RJ, Arbab-Zadeh A, George RT, et al. Aligning coronary anatomy and myocardial perfusion territories: an algorithm for the CORE320 multicenter study. Circ Cardiovasc Imaging. 2012;5(5):587-595. doi:10.1161/CIRCIMAGING.111.970608 |
| Peterson LR, Gropler RJ. Radionuclide imaging of myocardial metabolism. Circ Cardiovasc Imaging. 2010;3(2):211-222. doi:10.1161/CIRCIMAGING.109.860593 https://pubmed.ncbi.nlm.nih.gov/20233863/ |
| Sah BR, Husmann L, Mayer D, et al. Diagnostic performance of 18F-FDG-PET/CT in vascular graft infections. Eur J Vasc Endovasc Surg. 2015;49(4):455-464. doi: 10.1016/j.ejvs.2014.12.024 https://pubmed.ncbi.nlm.nih.gov/25648371/ |
| Henzlova MJ, Cerqueira MD, Hansen CL, et al. Stress protocols and tracers. ASNC guidelines. |
| Al-Mallah MH, Nayfeh M, Alrifai M. The role of cardiac PET in diagnosis and prognosis of patients with ischemia with no obstructive coronary arteries (INOCA). Am Heart J Plus. 2024;43:100399. Published 2024 May 18. doi:10.1016/j.ahjo.2024.100399 |
| Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016;133(24):2404-2412. doi:10.1161/CIRCULATIONAHA.116.021612 |
| Laukkanen JA, Mäkikallio TH, Rauramaa R, Kurl S. Asymptomatic ST-segment depression during exercise testing and the risk of sudden cardiac death in middle-aged men: a population-based follow-up study. Eur Heart J. 2009;30(5):558-565. doi:10.1093/eurheartj/ehn584 https://pubmed.ncbi.nlm.nih.gov/19168533/ Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation. 2000;102(10):1193-1209. doi:10.1161/01.cir.102.10.1193 https://pubmed.ncbi.nlm.nih.gov/10973852/ |
| Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, Gropler RJ, Knuuti J, Schelbert HR, Travin MI. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016 Oct;23(5):1187-1226. doi: 10.1007/s12350-016-0522-3. Epub 2016 Jul 8. Erratum in: J Nucl Cardiol. 2023 Oct;30(5):2186. doi: 10.1007/s12350-023-03357-6. PMID: 27392702. https://pubmed.ncbi.nlm.nih.gov/27392702/ |
| Regadenoson package insert, Astellas. |
| Roman CD, Habibian MR, Martin WH. Identification of an infected left ventricular assist device after cardiac transplant by indium-111 WBC scintigraphy. Clin Nucl Med. 2005 Jan;30(1):16-7. PubMed PMID: 15604960. Retrospective Study Comparing WBC scan and 18F-FDG PET/CT in Patients with Suspected Prosthetic Vascular Graft Infection. Puges, Mathilde et al. European Journal of Vascular and Endovascular Surgery, Volume 57, Issue 6, 876 – 884 Litzler PY, Manrique A, Etienne M, Salles A, Edet-Sanson A, Vera P, Bessou JP, Hitzel A. Leukocyte SPECT/CT for detecting infection of left-ventricular-assist devices: preliminary results. J Nucl Med. 2010 Jul;51(7):1044-8. doi: 10.2967/jnumed.109.070664. Epub 2010 Jun 16. PubMed PMID: 20554736. |
| Tezuka D, Haraguchi G, Ishihara T, Ohigashi H, Inagaki H, Suzuki J, Hirao K, Isobe M. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging. 2012 Apr;5(4):422-9. doi: 10.1016/j.jcmg.2012.01.013. PMID: 22498333. |
| Agarwal V, DePuey EG. Regadenoson and seizures: a real clinical concern. J Nucl Cardiol. 2014 Oct;21(5):869-70. doi: 10.1007/s12350-014-9970-9. Epub 2014 Aug 23. PMID: 25150095. |
| Williams KA, Hill KA, Sheridan CM. Noncardiac findings on dual-isotope myocardial perfusion SPECT. J Nucl Cardiol. 2003;10(4):395-402. doi:10.1016/s1071-3581(03)00524-5 |
| Chatal JF, Rouzet F, Haddad F, Bourdeau C, Mathieu C, Le Guludec D. Story of Rubidium-82 and Advantages for Myocardial Perfusion PET Imaging. Front Med (Lausanne). 2015 Sep 11;2:65. doi: 10.3389/fmed.2015.00065. PMID: 26442267; PMCID: PMC4566054. Ghotbi AA, Kjaer A, Hasbak P. Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging. Clin Physiol Funct Imaging. 2014 May;34(3):163-70. doi: 10.1111/cpf.12083. Epub 2013 Sep 13. PMID: 24028171; PMCID: PMC4204510. |
| ASNC Practice Points 99mTechnetium-Pyrophosphate Imaging for Transthyretin Cardiac Amyloidosis; https://www.asnc.org/Files/Practice%20Resources/Practice%20Points/ASNC%20Practice%20Point-99mTechnetiumPyrophosphateImaging2016.pdf |
| Wale et al. AJR 2015; 205:160–172 |
| Kitkungvan D, Bui L, Johnson NP, et al. Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity. Eur Heart J Cardiovasc Imaging. 2019;20(7):751-762. doi:10.1093/ehjci/jez080 https://pubmed.ncbi.nlm.nih.gov/31056681/ |
| Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW, Kudenchuk PJ, Ornato JP, McNally B, Silvers SM, Passman RS, White RD, Hess EP, Tang W, Davis D, Sinz E, Morrison LJ. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010 Nov 2;122(18 Suppl 3):S729-67. doi: 10.1161/CIRCULATIONAHA.110.970988. Erratum in: Circulation. 2011 Feb 15;123(6):e236. Erratum in: Circulation. 2013 Dec 24;128(25):e480. PMID: 20956224. |
| Taqueti VR, Di Carli MF. Radionuclide myocardial perfusion imaging for the evaluation of patients with known or suspected coronary artery disease in the era of multimodality cardiovascular imaging. Prog Cardiovasc Dis. 2015 May-Jun;57(6):644-53. doi: 10.1016/j.pcad.2015.03.004. Epub 2015 Mar 12. PMID: 25770849; PMCID: PMC5926794. |
| Anognostopoulos CD, Nihoyannopoulos P, Bax JJ, et al. Noninvasive Imaging of Myocardial Ischemia. Springer-Verlag. London. 2006. |
| Tanguay A, Lebon J, Lau L, Hébert D, Bégin F. Detection of STEMI Using Prehospital Serial 12-Lead Electrocardiograms. Prehosp Emerg Care. 2018;22(4):419-426. doi:10.1080/10903127.2017.1399185 https://pubmed.ncbi.nlm.nih.gov/16583653/ |
| Bokhari S, Sheikh T. Cardiac sarcoidosis: Advantages and limitations of advanced cardiac imaging. J Nucl Cardiol. 2022;29(5):2145-2148. doi:10.1007/s12350-021-02757-w https://pubmed.ncbi.nlm.nih.gov/34426934/ |
| Puges M, Bérard X, Ruiz JB, Debordeaux F, Desclaux A, Stecken L, Pereyre S, Hocquelet A, Bordenave L, Pinaquy JB, Cazanave C. Retrospective Study Comparing WBC scan and 18F-FDG PET/CT in Patients with Suspected Prosthetic Vascular Graft Infection. Eur J Vasc Endovasc Surg. 2019 Jun;57(6):876-884. doi: 10.1016/j.ejvs.2018.12.032. Epub 2019 May 23. PMID: 31130421. https://pubmed.ncbi.nlm.nih.gov/31130421/ Mahmoodi Z, Salarzaei M, Sheikh M. Prosthetic vascular graft infection: A systematic review and meta-analysis on diagnostic accuracy of 18FDG PET/CT. Gen Thorac Cardiovasc Surg. 2022 Mar;70(3):219-229. doi: 10.1007/s11748-021-01682-6. Epub 2021 Jul 26. PMID: 34309812. https://pubmed.ncbi.nlm.nih.gov/34309812/ |
| Bateman TM, Heller GV, Beanlands R, Calnon DA, Case J, deKemp R, DePuey EG, Di Carli M, Guler EC, Murthy VL, Rosenblatt J, Sher R, Slomka P, Ruddy TD. Practical Guide for Interpreting and Reporting Cardiac PET Measurements of Myocardial Blood Flow: An Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging. J Nucl Med. 2021 Nov;62(11):1599-1615. doi: 10.2967/jnumed.121.261989. Epub 2021 Mar 31. PMID: 33789935; PMCID: PMC8612323. https://pubmed.ncbi.nlm.nih.gov/33789935/ |
| Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, Birnie DH, Chen ES, Cooper LT, Tung RH, White ES, Borges-Neto S, Di Carli MF, Gropler RJ, Ruddy TD, Schindler TH, Blankstein R; NAME OF COLLAB GROUP. Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. J Nucl Med. 2017 Aug;58(8):1341-1353. doi: 10.2967/jnumed.117.196287. PMID: 28765228; PMCID: PMC6944184. https://pubmed.ncbi.nlm.nih.gov/28765228/ |
| DePuey EG, Morley J, Leykekhman A. Shifting breast attenuation artifact mimicking ischemia: Resolved with attenuation correction. J Nucl Cardiol. 2019; 26:2142-7. https://pubmed.ncbi.nlm.nih.gov/30460636/ |
| Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003 Jan;44(1):43-57. PMID: 12515876. https://pubmed.ncbi.nlm.nih.gov/12515876/ |
| Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. J Card Fail. 2019 Nov;25(11):e1-e39. doi: 10.1016/j.cardfail.2019.08.001. Epub 2019 Aug 29. Erratum in: J Card Fail. 2022 Jul;28(7):e1-e4. doi: 10.1016/j.cardfail.2021.06.012. PMID: 31473268. https://pubmed.ncbi.nlm.nih.gov/31473268/ Schockling EJ, Farrell MB, Embry-Dierson M, Warren J, Jerome S. Cardiac Amyloidosis Imaging, Part 2: Quantification and Technical Considerations. J Nucl Med Technol. 2023 Jun;51(2):90-98. doi: 10.2967/jnmt.123.265416. Epub 2023 Jun 2. PMID: 37268318. https://pubmed.ncbi.nlm.nih.gov/37268318/ Shetty M. A cardiology fellow’s take-home points from ASNC’s Webinar: Cases in Tc 99m-PYP evaluation of ATTR cardiac amyloidosis – interpretation and reporting. J Nucl Cardiol. 2021 Apr;28(2):604-609. doi: 10.1007/s12350-020-02516-3. Epub 2021 Mar 2. PMID: 33655447; PMCID: PMC7924912. https://pubmed.ncbi.nlm.nih.gov/33655447/ |
| Waring HJ, Bradley KM. Left Atrial Appendage Closure Devices May Demonstrate Significant 18 F-FDG Uptake in the Absence of Infection. Clin Nucl Med. 2024 Sep 1;49(9):e478-e479. doi: 10.1097/RLU.0000000000005341. Epub 2024 Jun 19. PMID: 38914049. https://pubmed.ncbi.nlm.nih.gov/38914049/ |
| Manabe O, Kikuchi T, Scholte AJHA, El Mahdiui M, Nishii R, Zhang MR, Suzuki E, Yoshinaga K. Radiopharmaceutical tracers for cardiac imaging. J Nucl Cardiol. 2018 Aug;25(4):1204-1236. doi: 10.1007/s12350-017-1131-5. Epub 2017 Dec 1. Erratum in: J Nucl Cardiol. 2018 Aug;25(4):1237-1241. doi: 10.1007/s12350-018-1184-0. PMID: 29196910; PMCID: PMC6133155. https://pubmed.ncbi.nlm.nih.gov/29196910/ Stendahl JC, Kwan JM, Pucar D, Sadeghi MM. Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 1: Technical Considerations and Perfusion and Neuronal Imaging. J Nucl Med. 2022 May;63(5):649-658. doi: 10.2967/jnumed.121.263506. PMID: 35487563; PMCID: PMC12079752. https://pubmed.ncbi.nlm.nih.gov/35487563/ |
Endocrine
| Nuclear Medicine: The Requisites, 4th Edition. Ziessman et al. |
| Greenspan BS, Dillehay G, Intenzo C, Lavely WC, O’Doherty M, Palestro CJ, Scheve W, Stabin MG, Sylvestros D, Tulchinsky M. SNM practice guideline for parathyroid scintigraphy 4.0. J Nucl Med Technol. 2012 Jun;40(2):111-8. doi: 10.2967/jnmt.112.105122. Epub 2012 Mar 27. PMID: 22454482. |
| Mittra ES, Niederkohr RD, Rodriguez C, El-Maghraby T, McDougall IR. Uncommon causes of thyrotoxicosis. J Nucl Med. 2008 Feb;49(2):265-78. doi: 10.2967/jnumed.107.041202. Epub 2008 Jan 16. PMID: 18199610. https://pubmed.ncbi.nlm.nih.gov/18199610/ |
| Rachinger W, Stoecklein VM, Terpolilli NA, et al. Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue. J Nucl Med. 2015;56(3):347-353. doi:10.2967/jnumed.114.149120 https://pubmed.ncbi.nlm.nih.gov/25635133/ |
| Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020. PMID: 26462967; PMCID: PMC4739132 |
| Hummel J, Wachsmann J, Carrick K, Oz OK, Mathews D, Peng F. Ectopic Thyroid Tissue in the Mediastinum Characterized by Histology and Functional Imaging with I-123 SPECT/CT. Case Rep Radiol. 2017;2017:9084207. doi:10.1155/2017/9084207 https://pubmed.ncbi.nlm.nih.gov/28251012/ |
| Mariani G, Tonacchera M, Grosso M, Orsolini F, Vitti P, Strauss HW. The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism. J Nucl Med. 2021 Mar;62(3):304-312. doi: 10.2967/jnumed.120.243170. Epub 2020 Oct 2. PMID: 33008929. |
| Mettler, F. A., & Guiberteau, M. J. (2018). Essentials of Nuclear Medicine and Molecular Imaging (7th ed.). Elsevier. Chapter 9 |
| Galindo RJ, Hurtado CR, Pasquel FJ, García Tome R, Peng L, Umpierrez GE. National Trends in Incidence, Mortality, and Clinical Outcomes of Patients Hospitalized for Thyrotoxicosis With and Without Thyroid Storm in the United States, 2004-2013. Thyroid. 2019 Jan;29(1):36-43. doi: 10.1089/thy.2018.0275. Epub 2018 Dec 18. PMID: 30382003; PMCID: PMC6916241. https://pubmed.ncbi.nlm.nih.gov/30382003/ Angell TE, Lechner MG, Nguyen CT, Salvato VL, Nicoloff JT, LoPresti JS. Clinical features and hospital outcomes in thyroid storm: a retrospective cohort study. J Clin Endocrinol Metab. 2015 Feb;100(2):451-9. doi: 10.1210/jc.2014-2850. Epub 2014 Oct 24. PMID: 25343237. https://pubmed.ncbi.nlm.nih.gov/30382003/ |
| Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018 Jan 13;391(10116):168-178. doi: 10.1016/S0140-6736(17)31430-7. Epub 2017 Sep 17. PMID: 28923463. https://pubmed.ncbi.nlm.nih.gov/28923463/ Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solórzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-968. doi: 10.1001/jamasurg.2016.2310. PMID: 27532368. https://pubmed.ncbi.nlm.nih.gov/28923463/ |
| Mariani G, Tonacchera M, Grosso M, Orsolini F, Vitti P, Strauss HW. The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism. J Nucl Med. 2021 Mar;62(3):304-312. doi: 10.2967/jnumed.120.243170. PMID: 33008929. https://pubmed.ncbi.nlm.nih.gov/33008929/ Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metab Clin North Am. 1998 Mar;27(1):169-85. doi: 10.1016/s0889-8529(05)70305-4. PMID: 9534035. https://pubmed.ncbi.nlm.nih.gov/9534035/ |
| Dong A, Cui Y, Wang Y, Zuo C, Bai Y. (18)F-FDG PET/CT of adrenal lesions. AJR Am J Roentgenol. 2014 Aug;203(2):245-52. doi: 10.2214/AJR.13.11793. PMID: 25055255. https://pubmed.ncbi.nlm.nih.gov/25055255/ |
| Wartofsky L, Van Nostrand D (eds). Thyroid Cancer: A Comprehensive Guide to Clinical Management. 3rd Ed. Springer Science+Business Media, New York, NY; 2016. |
Gastrointestinal
| Nuclear Medicine: The Requisites. Ziessman, O’Malley, Thrall eds. |
| Perlman SB, Hall BS, Reichelderfer M. PET/CT imaging of inflammatory bowel disease. Semin Nucl Med. 2013;43(6):420-426. doi:10.1053/j.semnuclmed.2013.06.006 |
| Janis O’Malley, Nuclear Medicine: The Requisites 4th Edition |
| Grady E. Gastrointestinal Bleeding Scintigraphy in the Early 21st Century. J Nucl Med. 2016 Feb;57(2):252-9. doi: 10.2967/jnumed.115.157289. Epub 2015 Dec 17. PMID: 26678616. |
| Willyard CE, Kalathil SC. Nuclear Medicine Liver/Spleen Test. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562325/ |
| Eldredge TA, Myers JC, Kiroff GK, Shenfine J. Detecting Bile Reflux-the Enigma of Bariatric Surgery. Obes Surg. 2018 Feb;28(2):559-566. doi: 10.1007/s11695-017-3026-6. PMID: 29230622. https://pubmed.ncbi.nlm.nih.gov/29230622/ |
| Elsayes KM, Menias CO, Harvin HJ, Francis IR. Imaging manifestations of Meckel’s diverticulum. AJR Am J Roentgenol. 2007;189(1):81-88. doi:10.2214/AJR.06.1257 https://pubmed.ncbi.nlm.nih.gov/17579156/ Spottswood SE, Pfluger T, Bartold SP, et al. SNMMI and EANM practice guideline for meckel diverticulum scintigraphy 2.0. J Nucl Med Technol. 2014;42(3):163-169. doi:10.2967/jnmt.113.13624 https://pubmed.ncbi.nlm.nih.gov/24948825/ |
| Farrell MB. Gastric Emptying Scintigraphy. J Nucl Med Technol. 2019 Jun;47(2):111-119. doi: 10.2967/jnmt.117.227892. PMID: 31167827. https://pubmed.ncbi.nlm.nih.gov/31167827/ |
| Peacock JG, Katchen JM, Christensen CT, Banks KP. Utilizing the Cholecystagoguehttps://pubmed.ncbi.nlm.nih.gov/31789906/, Ensure Plus, Results in Similar Hepatobiliary Scintigraphy Study Results and Patient Outcomes Status Post Cholecystectomy, in Comparison With Sincalide. Clin Nucl Med. 2020;45(1):1-6. doi:10.1097/RLU.0000000000002831 https://pubmed.ncbi.nlm.nih.gov/31789906/ |
| Chan DL, Hayes AR, Karfis I, Conner A, Furtado O’Mahony L, Mileva M, Bernard E, Roach P, Marin G, Pavlakis N, Schembri G, Gnanasegaran G, Marin C, Vanderlinden B, Navalkissoor S, Caplin ME, Flamen P, Toumpanakis C, Bailey DL. Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score. Br J Cancer. 2023 Feb;128(4):549-555. doi: 10.1038/s41416-022-02061-5. Epub 2022 Nov 25. PMID: 36434154; PMCID: PMC9938218. https://pubmed.ncbi.nlm.nih.gov/36434154/ |
| Sostre S, Kalloo AN, Spiegler EJ, Camargo EE, Wagner HN Jr. A noninvasive test of sphincter of Oddi dysfunction in postcholecystectomy patients: the scintigraphic score. J Nucl Med. 1992 Jun;33(6):1216-22. PMID: 1597742. https://pubmed.ncbi.nlm.nih.gov/1597742/ |
| Ng TSC, Putta N, Kwatra NS, Drubach LA, Rosen R, Fahey FH, Flores A, Nurko S, Voss SD. Pediatric Solid Gastric Emptying Scintigraphy: Normative Value Guidelines and Nonstandard Meal Alternatives. Am J Gastroenterol. 2020 Nov;115(11):1830-1839. PMID: 33156102. https://pubmed.ncbi.nlm.nih.gov/33156102/ Lai H, Vali R, Grant FD, Kwatra N, Chogle A, Bar-Sever Z, Zucchetta P, Gordon A, Smith L, Fisher T. The SNMMI Procedure Standard/EANM Practice Guideline for Pediatric Gastric Emptying. J Nucl Med Technol. 2025;53:198-204. PMID: 40169270. |
Genitourinary
| Satariano M, Ghose S, Raina R. The Pathophysiology of Inherited Renal Cystic Diseases. Genes (Basel). 2024;15(1):91. Published 2024 Jan 11. doi:10.3390/genes15010091 |
| SNM guidelines http://snmmi.files.cms-plus.com/docs/Renovascular_Hypertention.pdf |
| Uliel L, Mellnick VM, Menias CO, Holz AL, McConathy J. Nuclear medicine in the acute clinical setting: indications, imaging findings, and potential pitfalls. Radiographics. 2013;33(2):375-396. doi:10.1148/rg.332125098 |
| Boubaker A, Prior JO, Meuwly JY, Bischof-Delaloye A. Radionuclide investigations of the urinary tract in the era of multimodality imaging. J Nucl Med. 2006 Nov;47(11):1819-36. PMID: 17079816. Taylor AT. Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications. J Nucl Med. 2014 May;55(5):786-98. doi: 10.2967/jnumed.113.133454. Epub 2014 Mar 3. PMID: 24591488; PMCID: PMC4451959. |
| SUBCOMMITTEE ON URINARY TRACT INFECTION. Reaffirmation of AAP Clinical Practice Guideline: The Diagnosis and Management of the Initial Urinary Tract Infection in Febrile Infants and Young Children 2-24 Months of Age. Pediatrics. 2016;138(6):e20163026. doi:10.1542/peds.2016-3026 https://pubmed.ncbi.nlm.nih.gov/27940735/ |
| Mittal BR, Kumar P, Arora P, Kher V, Singhal MK, Maini A, Das BK. Role of captopril renography in the diagnosis of renovascular hypertension. Am J Kidney Dis. 1996 Aug;28(2):209-13. doi: 10.1016/s0272-6386(96)90303-0. PMID: 8768915. https://pubmed.ncbi.nlm.nih.gov/8768915/ |
| Majd M, Bar-Sever Z, Santos AI, De Palma D. The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children. J Nucl Med. 2018 Oct;59(10):1636-1640. doi: 10.2967/jnumed.118.215921. PMID: 30275286; PMCID: PMC6167528. https://pubmed.ncbi.nlm.nih.gov/30275286/ Conway JJ, Maizels M. The “well-tempered” diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis. A report from combined meetings of The Society for Fetal Urology and members of The Pediatric Nuclear Medicine Council–The Society of Nuclear Medicine. J Nucl Med. 1992 Nov;33(11):2047-51. PMID: 1432172. https://pubmed.ncbi.nlm.nih.gov/1432172/ |
| Conway JJ, Maizels M. The “well-tempered” diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis. A report from combined meetings of The Society for Fetal Urology and members of The Pediatric Nuclear Medicine Council–The Society of Nuclear Medicine. J Nucl Med. 1992;33(11):2047-2051. https://pubmed.ncbi.nlm.nih.gov/1432172/ Paltiel HJ, Rupich RC, Kiruluta HG. Enhanced detection of vesicoureteral reflux in infants and children with use of cyclic voiding cystourethrography. Radiology. 1992;184(3):753-755. doi:10.1148/radiology.184.3.1509062 https://pubmed.ncbi.nlm.nih.gov/1509062/ |
| Jung HS, Chung YA, Kim EN, et al. Influence of hydration status in normal subjects: fractional analysis of parameters of Tc-99m DTPA and Tc-99m MAG3 renography. Ann Nucl Med. 2005;19(1):1-7. doi:10.1007/BF02986328 https://pubmed.ncbi.nlm.nih.gov/15770966/ |
| Mettler FA, Guiberteau MJ. Essentials of Nuclear Medicine and Molecular Imaging. 7th Ed. Elsevier. |
| Bar-Sever Z, Shammas A, Gheisari F, Vali R. Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy. Semin Nucl Med. 2022;52(4):419-431. doi: 10.1053/j.semnuclmed.2021.12.002 https://pubmed.ncbi.nlm.nih.gov/35031115/ |
| ACR&;ACNM&;SNMMI&;SPR PRACTICE PARAMETER FOR THE PERFORMANCE OF RADIONUCLIDE CYSTOGRAPHY, Revised 2020 https://www.acr.org/-/media/ACR/Files/Practice-Parameters/RadionuclideCystog.pdf |
Neurology
| Chahid Y, Sheikh ZH, Mitropoulos M, Booij J. A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice. Eur J Nucl Med Mol Imaging. 2023;50(7):1974-1987. doi:10.1007/s00259-023-06171-x |
| Toriihara A, Yamaga E, Nakadate M, Oyama J, Tateishi U. Detection of unexpected emergency diseases using FDG-PET/CT in oncology patients. Jpn J Radiol. 2017 Sep;35(9):539-545. doi: 10.1007/s11604-017-0664-5. Epub 2017 Jul 3. PMID: 28674772. |
| Minoshima S, Mosci K, Cross D, Thientunyakit T. Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer’s Disease and Other Types of Dementing Disorders. Semin Nucl Med. 2021 May;51(3):230-240. doi: 10.1053/j.semnuclmed.2021.01.002. Epub 2021 Feb 2. PMID: 33546814. |
| Ponisio MR, Zempel JM, Day BK, Eisenman LN, Miller-Thomas MM, Smyth MD, Hogan RE. The Role of SPECT and PET in Epilepsy. AJR Am J Roentgenol. 2021 Mar;216(3):759-768. doi: 10.2214/AJR.20.23336. Epub 2021 Jan 21. |
| Honig LS, Barakos J, Dhadda S, et al. ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer’s disease. Alzheimer’s Dement (N Y). 2023;9(1):e12377. Published 2023 Mar 20. doi:10.1002/trc2.12377. https://pubmed.ncbi.nlm.nih.gov/36949897/ |
| ACR-ACNM-ASNR-SNMMI Practice Parameter for Brain PET-CT Imaging in Dementia. 2020; 41: 1-17 https://pubmed.ncbi.nlm.nih.gov/26646994/ |
| Deininger MH, Weyerbrock A. Gravitational valves in supine patients with ventriculo-peritoneal shunts. Acta Neurochir (Wien). 2009 Jun;151(6):705-9; discussion 709. doi: 10.1007/s00701-009-0291-8. Epub 2009 Apr 1. PMID: 19337679. MacDonald A, Burrell S. Infrequently performed studies in nuclear medicine: Part 1. J Nucl Med Technol. 2008 Sep;36(3):132-43; quiz 145. doi: 10.2967/jnmt.108.051383. Epub 2008 Aug 14. PMID: 18703616. |
| Brown RK, Bohnen NI, Wong KK, Minoshima S, Frey KA. Brain PET in suspected dementia: patterns of altered FDG metabolism. Radiographics. 2014;34(3):684-701. doi:10.1148/rg.343135065 https://pubmed.ncbi.nlm.nih.gov/24819789/ |
| Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson’s disease. Lancet. 2024 Jan 20;403(10423):293-304. doi: 10.1016/S0140-6736(23)01478-2. PMID: 38245249. https://pubmed.ncbi.nlm.nih.gov/38245249/ |
| Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010 Jan;9(1):119-28. doi: 10.1016/S1474-4422(09)70299-6. PMID: 20083042; PMCID: PMC2819840. |
| Lu J, Huang L, Lv Y, et al. A disease-specific metabolic imaging marker for diagnosis and progression evaluation of semantic variant primary progressive aphasia. Eur J Neurol. 2021;28(9):2927-2939. doi:10.1111/ene.14919 https://pubmed.ncbi.nlm.nih.gov/34110063/ |
Oncology
| Berrocal T, Madrid C, Novo S, Gutiérrez J, Arjonilla A, Gómez-León N. Congenital anomalies of the tracheobronchial tree, lung, and mediastinum: embryology, radiology, and pathology. Radiographics. 2004;24(1):e17. doi:10.1148/rg.e17 https://pubmed.ncbi.nlm.nih.gov/14610245/ |
| Thomas K, Farrell MB. How to write a protocol: part 2. J Nucl Med Technol. 2015;43(1):8-12. doi:10.2967/jnmt.114.151837 |
| Tirkes T, Hollar MA, Tann M, Kohli MD, Akisik F, Sandrasegaran K. Response criteria in oncologic imaging: review of traditional and new criteria. (2013) Radiographics : a review publication of the Radiological Society of North America, Inc. 33 (5): 1323-41. doi:10.1148/rg.335125214 |
| Adreview (Iobenguane I 123 Injection) full prescribing information. |
| Li D, Meng Z, Zhang G, Yu T, Tan J, Dong F. Visualization of thyroglossal duct cyst in differentiated thyroid cancer patient. Clin Nucl Med. 2010;35(7):499-504. doi: 10.1097/RLU.0b013e3181e05fe3 https://pubmed.ncbi.nlm.nih.gov/20548141/ |
| Newman EA, Cimmino VM, Sabel MS, et al. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol. 2006;13(1):52-57. doi:10.1245/ASO.2006.12.002 https://pubmed.ncbi.nlm.nih.gov/16372155/ Sood A, Youssef IM, Heiba SI, et al. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer. Clin Nucl Med. 2004;29(11):698-702. doi:10.1097/00003072-200411000-00005 https://pubmed.ncbi.nlm.nih.gov/15483481/ |
| Gontier E, Fourme E, Wartski M, et al. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging. 2008;35(1):95-99. doi:10.1007/s00259-007-0563-6 https://pubmed.ncbi.nlm.nih.gov/17786437/ Ozülker T, Ozülker F, Mert M, Ozpaçaci T. Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug. Eur J Nucl Med Mol Imaging. 2010;37(5):1011-1017. doi:10.1007/s00259-009-1330-7 https://pubmed.ncbi.nlm.nih.gov/20107796/ |
| Ozer E, Agrawal A, Ozer HG, Schuller DE. The impact of surgery in the management of the head and neck carcinoma involving the carotid artery. Laryngoscope. 2008 Oct;118(10):1771-4. doi: 10.1097/MLG.0b013e31817f6dc7. PMID: 18724260. |
| Keidar Z, Israel O, Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med. 2003 Jul;33(3):205-18. doi: 10.1053/snuc.2003.127310. PMID: 12931322. |
| Abe Y, Tamura K, Sakata I, Ishida J, Mukai M, Ohtaki M, Nakamura M, Machida K. Unique intense uptake demonstrated by (18)F-FDG positron emission tomography/computed tomography in primary pancreatic lymphoma: A case report. Oncol Lett. 2010 Jul;1(4):605-607. doi: 10.3892/ol_00000107. Epub 2010 Jul 1. PMID: 22966351; PMCID: PMC3436258. |
| Nadel HR. “Nuclear Oncology in Children”. Nuclear Medicine Annual 1996;143-193. |
| Deandreis D, Leboulleux S, Caramella C, Schlumberger M, Baudin E. FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma. Horm Cancer. 2011 Dec;2(6):354-62. doi: 10.1007/s12672-011-0091-5. PMID: 22076881; PMCID: PMC10358045. |
| Blumenkrantz Y, Bruno GL, González CJ, Namías M, Osorio AR, Parma P. Characterization of Elastofibroma Dorsi with (18)FDG PET/CT: a retrospective study. Rev Esp Med Nucl. 2011;30(6):342-345. doi: 10.1016/j.remn.2011.01.006 https://pubmed.ncbi.nlm.nih.gov/21466907/ Ochsner JE, Sewall SA, Brooks GN, Agni R. Best cases from the AFIP: Elastofibroma dorsi. Radiographics. 2006;26(6):1873-1876. doi:10.1148/rg.266055184 https://pubmed.ncbi.nlm.nih.gov/17102057/ |
| Mori H, Wakabayashi H, Saito S, et al. Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma. Sci Rep. 2024;14(1):13828. Published 2024 Jun 15. doi:10.1038/s41598-024-64607-2 https://pubmed.ncbi.nlm.nih.gov/38879654/ |
| Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007;25(5):571-578. doi:10.1200/JCO.2006.08.2305 |
| Yuan ST, Brown RK, Zhao L, ten Haken RK, Gross M, Cease KB, Schipper M, Stanton P, Yu J, Kong FM. Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy. Radiat Oncol. 2014 Jan 27;9(1):37. doi: 10.1186/1748-717X-9-37. PMID: 24467939; PMCID: PMC3996188. |
| Treglia G, Salsano M, Stefanelli A, Mattoli MV, Giordano A, Bonomo L. Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumors: a systematic review and a meta-analysis. Skeletal Radiol. 2012 Mar;41(3):249-56. doi: 10.1007/s00256-011-1298-9. Epub 2011 Nov 10. PMID: 22072239. McCarville MB, Christie R, Daw NC, Spunt SL, Kaste SC. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol. 2005 Apr;184(4):1293-304. doi: 10.2214/ajr.184.4.01841293. PMID: 15788613. |
| Neville HL, Andrassy RJ, Lally KP, Corpron C, Ross MI. Lymphatic mapping with sentinel node biopsy in pediatric patients. J Pediatr Surg. 2000 Jun;35(6):961-4. doi: 10.1053/jpsu.2000.6936. PMID: 10873044. Grant FD, Maclellan RA, Greene AK. (2014) , Lymphoscintigraphy. In: S. Ted Treves ed. Pediatric nuclear medicine and molecular imaging, 4th edition (pp. 189-202) Springer New York Heidelberg Dordrecht London. |
| Iyer RB, Balachandran A, Bruzzi JF, Johnson V, Macapinlac HA, Munden RF. PET/CT and hepatic radiation injury in esophageal cancer patients. Cancer Imaging. 2007 Nov 26;7(1):189-94. doi: 10.1102/1470-7330.2007.0027. PMID: 18055293; PMCID: PMC2151325. |
| Ziessman HA, O’Malley JP, Thrall JH. Nuclear Medicine: The Requisites, 4th Ed |
| Hain KS, Pickhardt PJ, Lubner MG, Menias CO, Bhalla S. Presacral masses: multimodality imaging of a multidisciplinary space. Radiographics. 2013 Jul-Aug;33(4):1145-67. doi: 10.1148/rg.334115171. PMID: 23842976. |
| https://www.novartis.com/us-en/sites/novartis_us/files/netspot.pdf |
| Motz K, Qualliotine JR, Rettig E, Richmon JD, Eisele DW, Fakhry C. Changes in Unknown Primary Squamous Cell Carcinoma of the Head and Neck at Initial Presentation in the Era of Human Papillomavirus. JAMA Otolaryngol Head Neck Surg. 2016 Mar;142(3):223-8. doi: 10.1001/jamaoto.2015.3228. PMID: 26769661. |
| Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. Value of PET/CT in the management of primary hepatobiliary tumors, part 2. AJR Am J Roentgenol. 2011 Aug;197(2):W260-5. doi: 10.2214/AJR.11.6995. PMID: 21785051. |
| Schoder H, Larson SM, SM.: Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med. 2004 Oct;34(4):274-92. PMID: 15493005 |
| Şimşek DH, Şanlı Y, Kuyumcu S, Başaran B, Mudun A. 68Ga-DOTATATE PET-CT imaging in carotid body paragangliomas. Ann Nucl Med. 2018;32(4):297-301. doi:10.1007/s12149-018-1242-3 https://pubmed.ncbi.nlm.nih.gov/29468487/ |
| Kaltsas G, Caplin M, Davies P, Ferone D, Garcia-Carbonero R, Grozinsky-Glasberg S, Hörsch D, Tiensuu Janson E, Kianmanesh R, Kos-Kudla B, Pavel M, Rinke A, Falconi M, de Herder WW; Antibes Consensus Conference participants. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors. Neuroendocrinology. 2017;105(3):245-254. doi: 10.1159/000461583. Epub 2017 Mar 2. PMID: 28253514; PMCID: PMC5637287. |
| Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE. PMID: 25763733 |
| Bartel TB, Kuruva M, Gnanasegaran G, Beheshti M, Cohen EJ, Weissman AF, Yarbrough TL. SNMMI Procedure Standard for Bone Scintigraphy 4.0. J Nucl Med Technol. 2018 Dec;46(4):398-404. PMID: 30518604. |
| Bartel TB, Kuruva M, Gnanasegaran G, et al. SNMMI Procedure Standard for Bone Scintigraphy 4.0. J Nucl Med Technol. 2018;46(4):398-404. https://pubmed.ncbi.nlm.nih.gov/30518604/ |
| Hope TA, Bergsland EK, Bozkurt MF, et al. Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors. J Nucl Med. 2018;59(1):66-74. doi:10.2967/jnumed.117.202275 https://pubmed.ncbi.nlm.nih.gov/29025982/ |
| Hope TA, Abbott A, Colucci K, Bushnell DL, Gardner L, Graham WS, Lindsay S, Metz DC, Pryma DA, Stabin MG, Strosberg JR. NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. J Nucl Med. 2019 Jul;60(7):937-943. doi: 10.2967/jnumed.118.230607. PMID: 31263080. |
| Montoriol PF, Boudinaud C. Ovarian metastases from ileal neuroendocrine tumour: Multimodality imaging. J Med Imaging Radiat Oncol. 2019 Jun;63(3):349-351. doi: 10.1111/1754-9485.12846. Epub 2018 Dec 26. PMID: 30585699. Tripathy S, Naswa N, Jha P, Reddy S, Parida GK. Ileal Neuroendocrine Tumor With Bilateral Breast and Ovarian Metastases: Findings on 68Ga-DOTANOC PET/CT Scan. Clin Nucl Med. 2019 Sep;44(9):e532-e534. doi: 10.1097/RLU.0000000000002685. PubMed PMID: 31274557. |
| Hall MN, Jagannathan JP, Ramaiya NH, Shinagare AB, Van den Abbeele AD. Imaging of extraosseous myeloma: CT, PET/CT, and MRI features. AJR Am J Roentgenol. 2010 Nov;195(5):1057-65. doi: 10.2214/AJR.10.4384. PMID: 20966307. |
| Soman AD, Collins JM, DePetris G, et al. Isolated supraclavicular lymph node metastasis in pancreatic adenocarcinoma: a report of three cases and review of the literature. JOP. 2010;11(6):604-609. Published 2010 Nov 9. https://pubmed.ncbi.nlm.nih.gov/21068495/ |
| Bartel TB, Kuruva M, Gnanasegaran G, et al. SNMMI Procedure Standard for Bone Scintigraphy 4.0. J Nucl Med Technol. 2018;46(4):398-404. https://pubmed.ncbi.nlm.nih.gov/30518604/ |
| Dittrich RP, Chowdhury YS. Nuclear Medicine Artifacts. [Updated 2021 Mar 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK568802/ |
| Kumar M, Salem K, Jeffery JJ, Yan Y, Mahajan AM, Fowler AM. Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating ESR1 Mutation. J Nucl Med. 2021 Apr;62(4):500-506. doi: 10.2967/jnumed.120.249508. Epub 2020 Aug 28. PMID: 32859700; PMCID: PMC8049365. |
| Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020. PMID: 26462967; PMCID: PMC4739132. |
| Mottet N, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042 https://pubmed.ncbi.nlm.nih.gov/33172724/ |
| Pour MC, Simon-Corat Y, Horne T. Diffuse increased uptake on bone scan: super scan. Semin Nucl Med. 2004 Apr;34(2):154-6. doi: 10.1053/j.semnuclmed.2003.12.005. PMID: 15031814. |
| Lodge MA. Repeatability of SUV in Oncologic 18F-FDG PET. J Nucl Med. 2017;58(4):523-532. doi:10.2967/jnumed.116.186353 https://pubmed.ncbi.nlm.nih.gov/28232605/ Weber WA, Ziegler SI, Thödtmann R, Hanauske AR, Schwaiger M. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med. 1999;40(11):1771-1777. https://pubmed.ncbi.nlm.nih.gov/10565769/ |
| Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. J Nucl Med. 2009;50(8):1237-1243. doi:10.2967/jnumed.108.060467 https://pubmed.ncbi.nlm.nih.gov/19617326/ |
| Kwak JJ, Tirumani SH, Van den Abbeele AD, Koo PJ, Jacene HA. Cancer immunotherapy: imaging assessment of novel treatment response patterns and immune-related adverse events. Radiographics. 2015 Mar-Apr;35(2):424-37. doi: 10.1148/rg.352140121. PMID: 25763727. Weber JS, Dummer R, de Pril V, Lebbé C, Hodi FS; MDX010-20 Investigators. Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma. Cancer. 2013 May 1;119(9):1675-82. doi: 10.1002/cncr.27969. Epub 2013 Feb 7. PMID: 23400564. |
| Tosoian JJ, Gorin MA, Ross AE, Pienta KJ, Tran PT, Schaeffer EM. Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations. Nat Rev Urol. 2017;14(1):15-25. doi:10.1038/nrurol.2016.175 https://pubmed.ncbi.nlm.nih.gov/27725639/ |
| Matalon SA, Mamon HJ, Fuchs CS, et al. Anorectal Cancer: Critical Anatomic and Staging Distinctions That Affect Use of Radiation Therapy. Radiographics. 2015;35(7):2090-2107. doi:10.1148/rg.2015150037 https://pubmed.ncbi.nlm.nih.gov/26562239/ |
| Langsteger W, Rezaee A, Pirich C, Beheshti M. 18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer. Semin Nucl Med. 2016;46(6):491-501. doi: 10.1053/j.semnuclmed.2016.07.003 https://pubmed.ncbi.nlm.nih.gov/27825429/ |
| Venema CM, de Vries EFJ, van der Veen SJ, et al. Enhanced pulmonary uptake on 18F-FES-PET/CT scans after irradiation of the thoracic area: related to fibrosis?. EJNMMI Res. 2019;9(1):82. Published 2019 Aug 23. doi:10.1186/s13550-019-0549-y https://pubmed.ncbi.nlm.nih.gov/31444658/ |
| Iyer PC, Cabanillas ME, Waguespack SG, et al. Immune-Related Thyroiditis with Immune Checkpoint Inhibitors. Thyroid. 2018;28(10):1243-1251. doi:10.1089/thy.2018.0116 https://pubmed.ncbi.nlm.nih.gov/30132401/ |
| Bélissant O, Champion L, Thevenet H, Weinmann P, Alberini JL. Value of 18F-FDG PET/CT imaging in the staging, restaging, monitoring of response to therapy and surveillance of uterine leiomyosarcomas. Nucl Med Commun. 2018;39(7):652-658. doi:10.1097/MNM.0000000000000848 https://pubmed.ncbi.nlm.nih.gov/29683931/ |
| Calais J, Zhu S, Hirmas N, et al. Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol. BMC Cancer. 2021;21(1):512. Published 2021 May 7. doi:10.1186/s12885-021-08026-w https://pubmed.ncbi.nlm.nih.gov/33962579/ Kessel K, Seifert R, Weckesser M, et al. Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imaging. Ann Nucl Med. 2022;36(3):293-301. doi:10.1007/s12149-021-01702-8 https://pubmed.ncbi.nlm.nih.gov/34854061/ |
| Paes FM, Singer AD, Checkver AN, Palmquist RA, De La Vega G, Sidani C. Perineural spread in head and neck malignancies: clinical significance and evaluation with 18F-FDG PET/CT. Radiographics. 2013 Oct;33(6):1717-36. doi: 10.1148/rg.336135501. PMID: 24108559. https://pubmed.ncbi.nlm.nih.gov/24108559/ Badger D, Aygun N. Imaging of Perineural Spread in Head and Neck Cancer. Radiol Clin North Am. 2017 Jan;55(1):139-149. doi: 10.1016/j.rcl.2016.08.006. PMID: 27890182. https://pubmed.ncbi.nlm.nih.gov/27890182/ |
| Manca G, Tardelli E, Rubello D, et al. Sentinel lymph node biopsy in breast cancer: a technical and clinical appraisal. Nucl Med Commun. 2016;37(6):570-576. doi:10.1097/MNM.0000000000000489 |
| Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. PMID: 30843003. https://pubmed.ncbi.nlm.nih.gov/30843003/ |
| Sharp SE, Trout AT, Weiss BD, Gelfand MJ. MIBG in Neuroblastoma Diagnostic Imaging and Therapy. Radiographics. 2016 Jan-Feb;36(1):258-78. doi: 10.1148/rg.2016150099. PMID: 26761540. https://pubmed.ncbi.nlm.nih.gov/26761540/ |
| Koh MJ, Sadarangani SP, Chan YC, Chan MY, Tan AM, Tan SH, Tay YK, Ng SB. Aggressive subcutaneous panniculitis-like T-cell lymphoma with hemophagocytosis in two children (subcutaneous panniculitis-like T-cell lymphoma). J Am Acad Dermatol. 2009 Nov;61(5):875-81. doi: 10.1016/j.jaad.2009.01.045. Epub 2009 Sep 9. PMID: 19744747. https://pubmed.ncbi.nlm.nih.gov/19744747/ Hung GD, Chen YH, Chen DY, Lan JL. Subcutaneous panniculitis-like T-cell lymphoma presenting with hemophagocytic lymphohistiocytosis and skin lesions with characteristic high-resolution ultrasonographic findings. Clin Rheumatol. 2007 May;26(5):775-8. doi: 10.1007/s10067-005-0193-y. Epub 2006 Feb 8. PMID: 16465478. https://pubmed.ncbi.nlm.nih.gov/16465478/ |
| Parida GK, Roy SG, Kumar R. FDG-PET/CT in Skeletal Muscle: Pitfalls and Pathologies. Semin Nucl Med. 2017 Jul;47(4):362-372. doi: 10.1053/j.semnuclmed.2017.02.003. Epub 2017 Apr 20. PMID: 28583276. https://pubmed.ncbi.nlm.nih.gov/28583276/ |
| Kumbhar SS, Qi J. Normal FDG uptake in the adenoids and palatine tonsils in children on PET/MRI. Pediatr Radiol. 2020 Jun;50(7):958-965. doi: 10.1007/s00247-020-04650-z. Epub 2020 Mar 20. PMID: 32198664. Okuyama C, Matsushima S, Nishimura M, Yamada K. Increased 18F-FDG accumulation in the tonsils after chemotherapy for pediatric lymphoma: a common physiological phenomenon. Ann Nucl Med. 2019 May;33(5):368-373. doi: 10.1007/s12149-019-01337-w. Epub 2019 Jan 28. PMID: 30689118. |
| Gafita A, Wang H, Robertson A, Armstrong WR, Zaum R, Weber M, Yagubbayli F, Kratochwil C, Grogan TR, Nguyen K, Navarro F, Esfandiari R, Rauscher I, Menze B, Elashoff D, Delpassand ES, Herrmann K, Czernin J, Hofman MS, Calais J, Fendler WP, Eiber M. Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality? J Nucl Med. 2022 Feb;63(2):226-232. doi: 10.2967/jnumed.121.261906. Epub 2021 May 28. PMID: 34049987; PMCID: PMC8805781. |
| Barrington SF, Kluge R. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):97-110. doi: 10.1007/s00259-017-3690-8. Epub 2017 Apr 14. PMID: 28411336; PMCID: PMC5541086. |
| Yeh R, Dercle L, Garg I, Wang ZJ, Hough DM, Goenka AH. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma. Abdom Radiol (NY). 2018;43(2):415-434. doi:10.1007/s00261-017-1374-2 https://pubmed.ncbi.nlm.nih.gov/29143875/ Araki T, Mouhieddine TH, Tirumani SH, et al. Focal Liver Uptake on FDG PET/CT Without CT Correlate: Utility of MRI in the Evaluation of Patients with Known Malignancy. AJR Am J Roentgenol. 2019;213(1):175-181. doi:10.2214/AJR.18.21035 https://pubmed.ncbi.nlm.nih.gov/30995099/ |
| https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Contrast-Manual Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74(7):932-987. doi:10.1016/j.jacc.2018.10.043 |
| Chen MY, Franklin A, Yaxley J, Gianduzzo T, McBean R, Wong D, Tatkovic A, McEwan L, Walters J, Kua B. Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging 68 Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant? BJU Int. 2020 Sep;126(3):396-401. doi: 10.1111/bju.15152. Epub 2020 Jul 28. PMID: 32592330. |
| Bhupathy SA, Huynh TV. Positive 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 20 Years after Talc Pleurodesis. World J Nucl Med. 2022;21(4):325-328. Published 2022 Sep 2. doi:10.1055/s-0042-1750394 |
| Kruse et al. AJR Am J Roentgenol. 2013 Aug;201(2): W215-26. doi: 10.2214/AJR.13.10572. PMID: 23883236 Yildirim et al. J Thorac Oncol. 2009 Dec;4(12):1480-4. PMID: 19875971 |
| Akkas, Burcu E.; Vural, Gulin U.. The incidence of secondary central nervous system involvement in patients with non-Hodgkin’s lymphoma as detected by 18F-FDG PET/CT. Nuclear Medicine Communications 34(1):p 50-56, January 2013. | DOI: 10.1097/MNM.0b013e32835aaa48 https://pubmed.ncbi.nlm.nih.gov/23111376/ Cheah CY, George A, Giné E, Chiappella A, Kluin-Nelemans HC, Jurczak W, Krawczyk K, Mocikova H, Klener P, Salek D, Walewski J, Szymczyk M, Smolej L, Auer RL, Ritchie DS, Arcaini L, Williams ME, Dreyling M, Seymour JF; European Mantle Cell Lymphoma Network. Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network. Ann Oncol. 2013 Aug;24(8):2119-23. doi: 10.1093/annonc/mdt139. Epub 2013 Apr 24. PMID: 23616279. https://pubmed.ncbi.nlm.nih.gov/23616279/ Lim CH, Hyun SH, Moon SH, et al. Clinical Significance of Incidental Focal 18F-FDG Uptake in the Spinal Cord of Patients with Cancer. Nucl Med Mol Imaging. 2017;51(3):247-251. doi:10.1007/s13139-016-0468-z https://pubmed.ncbi.nlm.nih.gov/28878851/ |
| Meissner VH, Rauscher I, Schwamborn K, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. 2022;82(2):156-160. doi:10.1016/j.eururo.2021.11.019 |
| Bombardieri E, Giammarile F, Aktolun C, Baum RP, Bischof Delaloye A, Maffioli L, Moncayo R, Mortelmans L, Pepe G, Reske SN, Castellani MR, Chiti A; European Association for Nuclear Medicine. 131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2436-46. doi: 10.1007/s00259-010-1545-7. PMID: 20644928. |
| Kutaiba N, Ardalan Z, Patwala K, Lau E, Goodwin M, Gow P. Value of Bone Scans in Work-up of Patients With Hepatocellular Carcinoma for Liver Transplant. Transplant Direct. 2018 Nov 23;4(12):e408. doi: 10.1097/TXD.0000000000000846. PMID: 30584589; PMCID: PMC6283090. Wong DC. Malignant ascites visualized on a radionuclide bone scan. Australas Radiol. 1998 Aug;42(3):246-7. doi: 10.1111/j.1440-1673.1998.tb00507.x. PMID: 9727256. |
| Rowe SP, Gorin MA, Gordetsky J, et al. Initial experience using 99mTc-MIBI SPECT/CT for the differentiation of oncocytoma from renal cell carcinoma. Clin Nucl Med. 2015;40(4):309-313. doi:10.1097/RLU.0000000000000670 https://pubmed.ncbi.nlm.nih.gov/25608174/ |
| Grabher BJ. 18F-Fluoroestradiol Whole-Body Imaging. J Nucl Med Technol. 2023 Sep;51(3):194-195. doi: 10.2967/jnmt.122.265271. PMID: 37669815. https://pubmed.ncbi.nlm.nih.gov/37669815/ |
| Ulaner GA. 16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients with Breast Cancer. Semin Nucl Med. 2022;52(5):574-583. doi: 10.1053/j.semnuclmed.2022.03.002 https://pubmed.ncbi.nlm.nih.gov/35379454/ |
| Zwezerijnen GJC, Eertink JJ, Ferrández MC, Wiegers SE, Burggraaff CN, Lugtenburg PJ, Heymans MW, de Vet HCW, Zijlstra JM, Boellaard R. Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):486-493. doi: 10.1007/s00259-022-05977-5. Epub 2022 Sep 27. PMID: 36166080; PMCID: PMC9816285. |
| Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015 Mar-Apr;35(2):500-16. doi: 10.1148/rg.352140164. PMID: 25763733. |
| Grabher BJ. Breast Cancer: Evaluating Tumor Estrogen Receptor Status with Molecular Imaging to Increase Response to Therapy and Improve Patient Outcomes. J Nucl Med Technol. 2020 Sep;48(3):191-201. doi: 10.2967/jnmt.119.239020. Epub 2020 Feb 28. Erratum in: J Nucl Med Technol. 2021 Mar;49(1):101. PMID: 32111662. https://pubmed.ncbi.nlm.nih.gov/32111662/ Mankoff D, Balogová S, Dunnwald L, Dehdashti F, DeVries E, Evangelista L, Van Kruchten M, Vaz SC, Fowler A, Linden H, Ulaner GA. Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[18F]Fluoro-17β-Estradiol PET. J Nucl Med. 2024 Feb 1;65(2):221-223. doi: 10.2967/jnumed.123.266938. PMID: 38071554 https://pubmed.ncbi.nlm.nih.gov/38071554/ |
| Arce MB, Molina TC, Hernández TM, de la Cinta Calvo Morón M, Herrero CH, De La Riva Pérez PA, Montaño JC. Thymic uptake after high-dose I-131 treatment in patients with differentiated thyroid carcinoma: a brief review of possible causes and management. Endocrinol Nutr. 2015 Jan;62(1):19-23. doi: 10.1016/j.endonu.2014.06.005. Epub 2014 Aug 24. PMID: 25160708. https://pubmed.ncbi.nlm.nih.gov/25160708/ Haghighatafshar M, Farhoudi F. Incidentally Visualization of the Thymus on Whole-Body Iodine Scintigraphy: Report of 2 Cases and Review of the Latest Insights. Medicine (Baltimore). 2015 Jul;94(26):e1015. doi: 10.1097/MD.0000000000001015. PMID: 26131804; PMCID: PMC4504571. https://pubmed.ncbi.nlm.nih.gov/26131804/ |
| Baffour FI, Wenger DE, Broski SM. 18F-FDG PET/CT imaging features of lipomatous tumors. Am J Nucl Med Mol Imaging. 2020 Feb 25;10(1):74-82. PMID: 32211221; PMCID: PMC7076300. https://pubmed.ncbi.nlm.nih.gov/32211221/> |
| Kim J, Lee S, Kim D, Kim HJ, Oh KT, Kim SJ, Choi YD, Giesel FL, Kopka K, Hoepping A, Lee M, Yun M. Combination of [18F]FDG and [18F]PSMA-1007 PET/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer. Eur J Nucl Med Mol Imaging. 2024 May;51(6):1763-1772. doi: 10.1007/s00259-023-06585-7. Epub 2024 Jan 11. PMID: 38200396. https://pubmed.ncbi.nlm.nih.gov/38200396/ |
| Yildiz H, Hakyemez B, Koroglu M, Yesildag A, Baykal B. Intracranial lipomas: importance of localization. Neuroradiology. 2006;48(1):1-7. doi:10.1007/s00234-005-0001-z https://pubmed.ncbi.nlm.nih.gov/16237548/ |
| Tuncel M, Kılıçkap S, Süslü N. Clinical impact of 68 Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer. Ann Nucl Med. 2020 Sep;34(9):663-674. doi: 10.1007/s12149-020-01494-3. Epub 2020 Jun 29. PMID: 32602032. |
| Mankoff D, Balogová S, Dunnwald L, Dehdashti F, DeVries E, Evangelista L, Van Kruchten M, Vaz SC, Fowler A, Linden H, Ulaner GA. Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16α-[18F]Fluoro-17β-Estradiol PET. J Nucl Med. 2024 Feb 1;65(2):221-223. doi: 10.2967/jnumed.123.266938. PMID: 38071554. https://pubmed.ncbi.nlm.nih.gov/38071554/ |
| Yun M, Cho A, Lee JH, Choi YJ, Lee JD, Kim CK. Physiologic 18F-FDG uptake in the fallopian tubes at mid cycle on PET/CT. J Nucl Med. 2010 May;51(5):682-5. doi: 10.2967/jnumed.109.074484. Epub 2010 Apr 15. PMID: 20395322. https://pubmed.ncbi.nlm.nih.gov/20395322/ |
| Stein SA, Wartofsky L. Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab. 2013 Aug;98(8):3131-8. doi: 10.1210/jc.2013-1428. Epub 2013 May 28. PMID: 23714679. https://pubmed.ncbi.nlm.nih.gov/23714679/ |
| Expert Panels on Neurological Imaging, Interventional Radiology, and Musculoskeletal Imaging, Khan MA, Jennings JW, et al. ACR Appropriateness Criteria® Management of Vertebral Compression Fractures: 2022 Update. J Am Coll Radiol. 2023;20(5S):S102-S124. doi: 10.1016/j.jacr.2023.02.015 https://pubmed.ncbi.nlm.nih.gov/37236738/ |
| Collarino A, del Ciello A, Perotti G, Rufini V. Intrapancreatic accessory spleen detected by 68Ga DOTANOC PET/CT and 99mTc-colloid SPECT/CT scintigraphy. Clin Nucl Med. 2015 May;40(5):415-8. doi: 10.1097/RLU.0000000000000601. PMID: 25275421. https://pubmed.ncbi.nlm.nih.gov/25275421/ |
Core
| Ulaner GA. 16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients With Breast Cancer. Semin Nucl Med. 2022;52(5):574-583. doi: 10.1053/j.semnuclmed.2022.03.002 https://pubmed.ncbi.nlm.nih.gov/35379454/ |
| https://www.ecfr.gov/current/title-10/chapter-I/part-35/subpart-M/section-35.3045 |
| Sensakovic WF, Flores M, Hough M. Occupational Dose and Dose Limits: Experience in a Large Multisite Hospital System. J Am Coll Radiol. 2016 Jun;13(6):649-55. doi: 10.1016/j.jacr.2016.01.014. Epub 2016 Mar 29. PMID: 27033162. https://pubmed.ncbi.nlm.nih.gov/27033162/ |
| Mettler, Fred A., Guiberteau, Milton J. 2006 Essential of nuclear medicine imaging 5th edition |
| Catana C, Guimaraes AR, Rosen BR. PET and MR imaging: the odd couple or a match made in heaven?. J Nucl Med. 2013;54(5):815-824. doi:10.2967/jnumed.112.112771 https://pubmed.ncbi.nlm.nih.gov/23492887/ |
| Al-Naser YA, Tafti D. MRI Patient Safety And Care. [Updated 2024 Feb 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK604477/ https://pubmed.ncbi.nlm.nih.gov/38917267/ |
| The Essential Physics of Medical Imaging by Bushburg |
| Kaza RK, Platt JF, Goodsitt MM, et al. Emerging techniques for dose optimization in abdominal CT. Radiographics. 2014;34(1):4-17. doi:10.1148/rg.341135038 https://pubmed.ncbi.nlm.nih.gov/24428277/ |
| Zanzonico P. Routine quality control of clinical nuclear medicine instrumentation: a brief review. J Nucl Med. 2008;49(7):1114-1131. doi:10.2967/jnumed.107.050203 |
| Amin K et al. Radiation exposure from handling alpha emitting radiopharmaceutical radium-223 dichloride with and without syringe shield. J Nucl Med May 2014 vol. 55 no. supplement 1 2505. Carnicer, A. et al. Occupational Exposure: With Special Reference to Skin Doses in Hands and Fingers. In Radiation Protection in Nuclear Medicine (Ed) Mattsson, S. Hoeschen,C. Springer 2013. ICRP, 2008. Radiation Dose to Patients from Radiopharmaceuticals – Addendum 3 to ICRP Publication 53. ICRP Publication 106. Ann. ICRP 38 (1-2). |
| Bottinor W, Polkampally P, Jovin I. Adverse reactions to iodinated contrast media. Int J Angiol. 2013;22(3):149-154. doi:10.1055/s-0033-1348885 https://pubmed.ncbi.nlm.nih.gov/24436602/ Beckett KR, Moriarity AK, Langer JM. Safe Use of Contrast Media: What the Radiologist Needs to Know. Radiographics. 2015;35(6):1738-1750. doi:10.1148/rg.2015150033 https://pubmed.ncbi.nlm.nih.gov/26466182/ |
| ACR–ACNM–SNMMI Practice Parameter for the performance of Gallium-68 and Copper-64 DOTATATE PET/CT imaging for neuroendocrine tumors, Rev. 2023, https://gravitas.acr.org/PPTS/DownloadPreviewDocument?DocId=18 |
| Hofman MS, Hicks RJ, Maurer T, Eiber M. Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls. Radiographics. 2018 Jan-Feb;38(1):200-217. doi: 10.1148/rg.2018170108. PMID: 29320333. |
| Blodgett TM, Mehta AS, Mehta AS, Laymon CM, Carney J, Townsend DW. PET/CT artifacts. Clin Imaging. 2011;35(1):49-63. doi:10.1016/j.clinimag.2010.03.001 |
| Wale DJ, Wong KK, Savas H, Kandathil A, Piert M, Brown RK. Extraosseous Findings on Bone Scintigraphy Using Fusion SPECT/CT and Correlative Imaging. AJR Am J Roentgenol. 2015;205(1):160-172. doi:10.2214/AJR.14.13914 |
| Vali R, Alessio A, Balza R, Borgwardt L, Bar-Sever Z, Czachowski M, Jehanno N, Kurch L, Pandit-Taskar N, Parisi M, Piccardo A, Seghers V, Shulkin BL, Zucchetta P, Lim R. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0. J Nucl Med. 2021 Jan;62(1):99-110. doi: 10.2967/jnumed.120.254110. PMID: 33334912; PMCID: PMC8679588. |
| Malan N, Vangu MD. Normal Variants, Pitfalls, and Artifacts in Ga-68 Prostate Specific Membrane Antigen (PSMA) PET/CT Imaging. Front Nucl Med. 2022;2:825512. Published 2022 Feb 21. doi:10.3389/fnume.2022.825512 |
| Caution signs, 10 C.F.R. § 20.1901 (1995). https://www.nrc.gov/reading-rm/doc-collections/cfr/part020/full-text#part020-1004 |
| Osman MM, Muzaffar R, Altinyay ME, Teymouri C. FDG Dose Extravasations in PET/CT: Frequency and Impact on SUV Measurements. Front Oncol. 2011 Nov 16;1:41. doi: 10.3389/fonc.2011.00041. PMID: 22655246; PMCID: PMC3356044. https://pubmed.ncbi.nlm.nih.gov/22655246/ |
| Basu S, Hess S, Nielsen Braad PE, Olsen BB, Inglev S, Høilund-Carlsen PF. The Basic Principles of FDG-PET/CT Imaging. PET Clin. 2014 Oct;9(4):355-70, v. doi: 10.1016/j.cpet.2014.07.006. Epub 2014 Aug 5. PMID: 26050942. https://pubmed.ncbi.nlm.nih.gov/26050942/ |
| Zanzonico P. Routine quality control of clinical nuclear medicine instrumentation: a brief review. J Nucl Med. 2008;49(7):1114-1131. doi:10.2967/jnumed.107.050203 https://pubmed.ncbi.nlm.nih.gov/18587088/ |
| Sorenson JA and Phelps ME. Physics in Nuclear Medicine, Second Edition, Chapter 3: Decay of Radioactivity. |
Therapy
| American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009 Nov;19(11):1167-214. doi: 10.1089/thy.2009.0110. Erratum in: Thyroid. 2010 Aug;20(8):942. Hauger, Bryan R [corrected to Haugen, Bryan R]. Erratum in: Thyroid. 2010 Jun;20(6):674-5. PMID: 19860577. |
| Kluetz PG, Pierce W, Maher VE, et al. Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary. Clin Cancer Res. 2014;20(1):9-14. doi: 10.1158/1078-0432.CCR-13-2665 https://pubmed.ncbi.nlm.nih.gov/24190979/ |
| Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O’Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. PMID: 28076709; PMCID: PMC5895095. |
| Sönmez B, Bektaş Ö, Erkut N, Sönmez M. Assessment of Long-Term Hematologic Effects in Differentiated Thyroid Cancer Patients Treated with Radioactive Iodine. Turk J Haematol. 2021;38(4):306-313. doi:10.4274/tjh.galenos.2021.2021.0092 |
| Xofigo package insert |
| Thyrogen package insert; https://products.sanofi.us/Thyrogen/Thyrogen.pdf https://products.sanofi.us/Thyrogen/thyrogen.pdf |
| Sartor O, Coleman RE, Nilsson S, et al. An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223. Ann Oncol. 2017;28(5):1090-1097. doi:10.1093/annonc/mdx044 https://pubmed.ncbi.nlm.nih.gov/28453701/ |
| https://labeling.bayerhealthcare.com/html/products/pi/Xofigo_PI.pdf |
| Reiners C, Schneider P. Radioiodine therapy of thyroid autonomy. Eur J Nucl Med Mol Imaging. 2002;29 Suppl 2:S471-S478. doi:10.1007/s00259-002-0910-6 https://pubmed.ncbi.nlm.nih.gov/12192548/ |
| Pluvicto Package Insert https://www.novartis.com/us-en/sites/novartis_us/files/pluvicto.pdf |
| Kratochwil C, Fendler WP, Eiber M, et al. EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2019;46(12):2536-2544. doi:10.1007/s00259-019-04485-3 https://pubmed.ncbi.nlm.nih.gov/31440799/ |
| Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460. PMID: 25900731; PMCID: PMC4854274. |
| Silberstein EB, Alavi A, Balon HR, et al. The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med. 2012;53(10):1633-1651. doi:10.2967/jnumed.112.105148 https://pubmed.ncbi.nlm.nih.gov/22787108/ |
| https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208700s000lbl.pdf |
| Strosberg JR, Al-Toubah T, Pellè E, et al. Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide Therapy. J Nucl Med. 2021;62(1):69-72. doi:10.2967/jnumed.120.242875 https://pubmed.ncbi.nlm.nih.gov/32444368/ |
| Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-1421. doi: 10.1089/thy.2016.0229. Erratum in: Thyroid. 2017 Nov;27(11):1462. PMID: 27521067. https://pubmed.ncbi.nlm.nih.gov/27521067/ |
| Silberstein EB, Alavi A, Balon HR, Clarke SE, Divgi C, Gelfand MJ, Goldsmith SJ, Jadvar H, Marcus CS, Martin WH, Parker JA, Royal HD, Sarkar SD, Stabin M, Waxman AD. The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med. 2012 Oct;53(10):1633-51. doi: 10.2967/jnumed.112.105148. Epub 2012 Jul 11. PMID: 22787108. https://pubmed.ncbi.nlm.nih.gov/22787108/ |
| https://www.novartis.com/us-en/sites/novartis_us/files/pluvicto.pdf https://www.novartis.com/us-en/sites/novartis_us/files/pluvicto.pdf |
| https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215833s000lbl.pdf |
| Bonta DV, Halkar RK, Alazraki N. Extravasation of a therapeutic dose of 131I-metaiodobenzylguanidine: prevention, dosimetry, and mitigation. J Nucl Med. 2011 Sep;52(9):1418-22. doi: 10.2967/jnumed.110.083725. Epub 2011 Jul 27. PMID: 21795365. https://pubmed.ncbi.nlm.nih.gov/21795365/ van der Pol J, Vöö S, Bucerius J, Mottaghy FM. Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review. Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1234-1243. doi: 10.1007/s00259-017-3675-7. Epub 2017 Mar 16. PMID: 28303300; PMCID: PMC5434120. https://pubmed.ncbi.nlm.nih.gov/28303300/ |
| do Vale RH, Sado HN, Danilovic DL, Duarte PS, Sapienza MT. Incidental diagnosis of struma ovarii through radioiodine whole-body scanning: incremental role of SPECT/CT. Radiol Bras. 2016;49(2):126-127. doi:10.1590/0100-3984.2015.0027 https://pubmed.ncbi.nlm.nih.gov/27141138/ |
| The Requisites: Nuclear Medicine |
| Jin Y, Zhang Y, Wang M, Bai X, Ping H, Xing N. Adverse events associated with Lutetium-177-PSMA-617 (Pluvicto®) in advanced prostate cancer: a disproportionality analysis based on the fda’s adverse event reporting system (FAERS). BMC Cancer. 2025;25(1):1470. Published 2025 Sep 30. doi:10.1186/s12885-025-14846-x |
Pulmonary
| Parker JA, Coleman RE, Grady E, Royal HD, Siegel BA, Stabin MG, Sostman HD, Hilson AJ; Society of Nuclear Medicine. SNM practice guideline for lung scintigraphy 4.0. J Nucl Med Technol. 2012 Mar;40(1):57-65. doi: 10.2967/jnmt.111.101386. Epub 2012 Jan 26. Erratum in: J Nucl Med Technol. 2016 Dec;44(4):271. PMID: 22282651. |
| Ventilation/Perfusion Scintigraphy , William G. Spies in Nuclear Medicine , Vol 2, Chapter 90, text book by Robert Henkin |
| Gandhi SJ, Babu S, Subramanyam P, Shanmuga Sundaram P. Tc-99m macro aggregated albumin scintigraphy – indications other than pulmonary embolism: A pictorial essay. Indian J Nucl Med. 2013;28(3):152-162. doi:10.4103/0972-3919.119546 |
| Slavin JD Jr, Sherigar RM, Spencer RP. Ventilation-perfusion “reverse mismatch” from aspirated medication. Clin Nucl Med. 1998 Oct;23(10):719-20. doi: 10.1097/00003072-199810000-00025. PMID: 9790061. Wartski M, Zerbib E, Regnard JF, Hervé P. Reverse ventilation-perfusion mismatch in lung cancer suggests intrapulmonary functional shunting. J Nucl Med. 1998 Nov;39(11):1986-9. PMID: 9829595. |
| Ventilation-Perfusion Scan: A Primer for Practicing Radiologists. Paul-Robert Derenoncourt, Gabriel J. Felder, Henry D. Royal, Sanjeev Bhalla, Jordan A. Lang, Manuela C. Matesan, and Malak Itani. RadioGraphics 2021 41:7, 2047-2070 |
| Graves MW, Kiratli PO, Mozley D, Palevsky H, Zukerberg B, Alavi A. Scintigraphic diagnosis of a right to left shunt in end-stage lung disease. Respir Med. 2003;97(5):549-554. doi:10.1053/rmed.2003.1481 |
| Remy-Jardin M, Ryerson CJ, Schiebler ML, Leung ANC, Wild JM, Hoeper MM, Alderson PO, Goodman LR, Mayo J, Haramati LB, Ohno Y, Thistlethwaite P, van Beek EJR, Knight SL, Lynch DA, Rubin GD, Humbert M. Imaging of pulmonary hypertension in adults: a position paper from the Fleischner Society. Eur Respir J. 2021 Jan 5;57(1):2004455. doi: 10.1183/13993003.04455-2020. PMID: 33402372. Pulmonary Hypertension: Pearls and Pitfalls of Diagnosis. Methodist Debakey Cardiovasc J. 2016 Oct-Dec;12(4):199-204. doi: 10.14797/mdcj-12-4-199. PMID: 28289494; PMCID: PMC5344469. |
| Radioactivity, Radionuclides, and Radiopharmaceuticals (Chapter 1). Mettler, Fred A.; Guiberteau, Milton J. Essentials of Nuclear Medicine and Molecular Imaging E-Book . Elsevier Health Sciences. SNM Practice Guideline for Lung Scintigraphy 4.0 J. Anthony Parker, R. Edward Coleman, Erin Grady, Henry D. Royal, Barry A. Siegel, Michael G. Stabin, H. Dirk Sostman and Andrew J.W. Hilson |
| Bowman AW, Albers BK, Jain MK. Acquired Whole-lung Mismatched Perfusion Defects on Pulmonary Ventilation/Perfusion Scintigraphy. Indian J Nucl Med. 2018 Oct-Dec;33(4):312-316. doi: 10.4103/ijnm.IJNM_60_18. PMID: 30386053; PMCID: PMC6194779. |
| Pediatric Nuclear Medicine and Molecular Imaging, S. Ted Treves, Chapter 6. |
| Milanesi O, Stellin G, Zucchetta P. Nuclear Medicine in Pediatric Cardiology. Semin Nucl Med. 2017 Mar;47(2):158-169. doi: 10.1053/j.semnuclmed.2016.10.008. Epub 2017 Jan 10. PMID: 28237004. |
| Barasch M, Rickley C, Intenzo C, Kim S. Imaging Approach in Patients With Right to Left Shunting. Journal of Nuclear Medicine May 2017, 58 (supplement 1) 1138; |
Musculoskeletal
| Mitchell MD, Kundel HL, Steinberg ME, Kressel HY, Alavi A, Axel L. Avascular necrosis of the hip: comparison of MR, CT, and scintigraphy. AJR Am J Roentgenol. 1986 Jul;147(1):67-71. doi: 10.2214/ajr.147.1.67. PMID: 3487233. |
| Palestro C, Clark A, Grady E, et al. Appropriate Use Criteria for the Use of Nuclear Medicine in Musculoskeletal Infection Imaging. J Nucl Med. Published online September 30, 2021. doi:10.2967/jnumed.121.262579 |
| Parikh J, Hyare H, Saifuddin A. The imaging features of post-traumatic myositis ossificans, with emphasis on MRI. Clin Radiol. 2002;57(12):1058-1066. doi:10.1053/crad.2002.1120 https://pubmed.ncbi.nlm.nih.gov/12475528/ Tyler P, Saifuddin A. The imaging of myositis ossificans. Semin Musculoskelet Radiol. 2010;14(2):201-216. doi:10.1055/s-0030-1253161 https://pubmed.ncbi.nlm.nih.gov/20486028/ |
| Blake GM, Fogelman I. An update on dual-energy x-ray absorptiometry. Semin Nucl Med. 2010;40(1):62-73. doi: 10.1053/j.semnuclmed.2009.08.001 https://pubmed.ncbi.nlm.nih.gov/19958851/ |
| Cheon M, Yoo J. Metastatic Pulmonary Calcification Detected on 18F-FDG PET/CT and 99mTc-MDP Bone Scan. Diagnostics (Basel). 2021;11(9):1627. Published 2021 Sep 6. doi:10.3390/diagnostics11091627 |
| Dittrich RP, Chowdhury YS. Nuclear Medicine Artifacts. [Updated 2021 Mar 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK568802/ |
| Askari E, Shakeri S, Roustaei H, et al. Superscan Pattern on Bone Scintigraphy: A Comprehensive Review. Diagnostics (Basel). 2024;14(19):2229. Published 2024 Oct 6. doi:10.3390/diagnostics14192229 |
| Adams C, Banks KP. Bone Scan. 2023 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30285381. https://pubmed.ncbi.nlm.nih.gov/30285381/ |
| Morag Y, Morag-Hezroni M, Jamadar DA, Ward BB, Jacobson JA, Zwetchkenbaum SR, Helman J. Bisphosphonate-related osteonecrosis of the jaw: a pictorial review. Radiographics. 2009 Nov;29(7):1971-84. doi: 10.1148/rg.297095050. PMID: 19926757. |
| Hod N, Levi Y, Fire G, Cohen I, Ayash D, Somekh M, Horne T. Scintigraphic characteristics of non-ossifying fibroma in military recruits undergoing bone scintigraphy for suspected stress fractures and lower limb pains. Nucl Med Commun. 2007 Jan;28(1):25-33. doi: 10.1097/MNM.0b013e328012e3de. PMID: 17159546. Dumitriu DI, Menten R, Clapuyt P. Pitfalls in the diagnosis of common benign bone tumours in children. Insights Imaging. 2014 Dec;5(6):645-55. doi: 10.1007/s13244-014-0356-y. Epub 2014 Sep 26. PMID: 25256565; PMCID: PMC4263798. |
| Palestro C, Clark A, Grady E, Heiba S, Israel O, Klitzke A, Love C, Sathekge M, Treves ST, Yarbrough TL. Appropriate Use Criteria for the Use of Nuclear Medicine in Musculoskeletal Infection Imaging. J Nucl Med. 2021 Sep 30;62(12):1815–31. doi: 10.2967/jnumed.121.262579. Epub ahead of print. PMID: 34593597; PMCID: PMC8612196. https://pubmed.ncbi.nlm.nih.gov/3459359/ Love C, Palestro CJ. Nuclear medicine imaging of bone infections. Clin Radiol. 2016 Jul;71(7):632-46. doi: 10.1016/j.crad.2016.01.003. Epub 2016 Feb 17. PMID: 26897336. https://pubmed.ncbi.nlm.nih.gov/26897336/ |
| ISCD Adult Positions, accessible at https://iscd.org/learn/official-positions/adult-positions/ https://iscd.org/learn/official-positions/adult-positions/ |
| Banks KP, Farrell MB, Gunther RS, McWhorter NE, Byerly DW, Peacock JG. Improving DXA Quality by Avoiding Common Technical and Diagnostic Pitfalls: Part 1. J Nucl Med Technol. 2023;51(3):167-175. doi:10.2967/jnmt.122.264885 https://pubmed.ncbi.nlm.nih.gov/36195442/ Morin SN, Leslie WD, Schousboe JT. Osteoporosis: A Review. JAMA. 2025;334(10):894-907. doi:10.1001/jama.2025.6003 https://pubmed.ncbi.nlm.nih.gov/40587168/ Slart RHJA, Punda M, Ali DS, et al. Updated practice guideline for dual-energy X-ray absorptiometry (DXA). Eur J Nucl Med Mol Imaging. 2025;52(2):539-563. doi:10.1007/s00259-024-06912-6 https://pubmed.ncbi.nlm.nih.gov/39316095/ |